 0 Table of Contents |
  1 Home Page |
  2 Mapping Background |
   2.1 Mapping General and Structural Guidance |
   2.2 C-CDA → FHIR Index |
    2.2.1 C-CDA to FHIR Patient |
    2.2.2 C-CDA to FHIR Participations |
    2.2.3 C-CDA to FHIR Allergies |
    2.2.4 C-CDA to FHIR Encounters |
    2.2.5 C-CDA to FHIR Immunizations |
    2.2.6 C-CDA to FHIR Medications |
    2.2.7 C-CDA to FHIR Notes |
    2.2.8 C-CDA to FHIR Problems |
    2.2.9 C-CDA to FHIR Procedures |
    2.2.10 C-CDA to FHIR Results |
    2.2.11 C-CDA to FHIR Social History |
    2.2.12 C-CDA to FHIR Vital Signs |
   2.3 FHIR → C-CDA Index |
    2.3.1 FHIR to C-CDA Patient |
    2.3.2 FHIR to C-CDA Allergies |
    2.3.3 FHIR to C-CDA Encounters |
    2.3.4 FHIR to C-CDA Immunizations |
    2.3.5 FHIR to C-CDA Medications |
    2.3.6 FHIR to C-CDA Notes |
    2.3.7 FHIR to C-CDA Problems |
    2.3.8 FHIR to C-CDA Procedures |
    2.3.9 FHIR to C-CDA Results |
    2.3.10 FHIR to C-CDA Social History |
    2.3.11 FHIR to C-CDA Vital Signs |
   2.4 Terminology Maps (Concept Maps) |
   2.5 Change Log |
   2.6 Known Issues |
  3 Artifacts Summary |
   3.1 C-CDA to FHIR Address Use |
   3.2 C-CDA to FHIR Administrative Gender |
   3.3 CCDA to FHIR Allergy Intolerance Category |
   3.4 CCDA to FHIR Allergy Intolerance Type |
   3.5 C-CDA to FHIR Allergy Status |
   3.6 CCDA Problem Concern Status to FHIR Condition Clinical Status |
   3.7 CCDA Criticality to FHIR Criticality |
   3.8 C-CDA to FHIR Encounter Status |
   3.9 C-CDA to FHIR Immunization Status |
   3.10 CCDA Medication Activity Mood to FHIR MedicationRequest.intent |
   3.11 C-CDA to FHIR Medication Status |
   3.12 C-CDA to FHIR NameUse |
   3.13 C-CDA to FHIR No Known Allergies |
   3.14 C-CDA NullFlavor to FHIR Data Absent Reason |
   3.15 C-CDA section to FHIR Condition category code |
   3.16 C-CDA Problem Status value to FHIR Condition clinicalStatus |
   3.17 C-CDA to FHIR Procedure Status |
   3.18 CCDA ResultStatus to FHIR DiagnosticReport status |
   3.19 CCDA ResultStatus to FHIR Observation Status |
   3.20 C-CDA Severity to FHIR Severity |
   3.21 C-CDA to FHIR Telecom Type |
   3.22 C-CDA to FHIR Telecom Use |
   3.23 FHIR to C-CDA Address Use |
   3.24 FHIR to C-CDA Administrative Gender |
   3.25 FHIR to CCDA Allergy Intolerance Category |
   3.26 FHIR Allergy Intolerance Type to CCDA value |
   3.27 FHIR to C-CDA Allergy Status |
   3.28 FHIR Criticality to C-CDA Criticality |
   3.29 FHIR Data Absent Reason to C-CDA NullFlavor |
   3.30 FHIR Immunization Status Reason to C-CDA Immunization Refusal |
   3.31 FHIR Immunization Site to C-CDA Immunization approachSiteCode |
   3.32 FHIR to C-CDA Immunization Status |
   3.33 FHIR to C-CDA Medication Status |
   3.34 FHIR to C-CDA NameUse |
   3.35 FHIR to C-CDA No Known Allergies |
   3.36 FHIR ObservationStatus to C-CDA ObservationStatus |
   3.37 FHIR Condition category to C-CDA section code |
   3.38 FHIR Condition clinicalStatus to C-CDA Problem Status value |
   3.39 FHIR to C-CDA Procedure Status |
   3.40 FHIR Severity to C-CDA Severity |
   3.41 FHIR to C-CDA Telecom Type |
   3.42 FHIR to C-CDA Telecom Use |
   3.43 ccda-practitionerrole-example |
   3.44 Practitioner Brenda Jennings Richard |
   3.45 CF-patient-example |
   3.46 CF-allergy-example |
   3.47 FC-allergy-example |
   3.48 CF-immunization-example |
   3.49 FC-immunization-example |
   3.50 CF-medication-example |
   3.51 FC-medication-example |
   3.52 CF-problem-example |
   3.53 FC-problem-example |
   3.54 CF-procedure-example |
   3.55 Acme Clinic |
   3.56 Acme Labs |
   3.57 CF-allergy |
   3.58 CF-immunization |
   3.59 CF-medication |
   3.60 CF-patient |
   3.61 CF-problem |
   3.62 CF-procedure |
   3.63 FC-allergy |
   3.64 FC-immunization |
   3.65 FC-medication |
   3.66 FC-problem |